Keywords: ml, labs, defends, itself, against, icodextrin, study

ML Labs defends itself against icodextrin study

Article | 16 March 2000

Print This

A key component of treatments made by ML Laboratories, calledicodextrin, may be responsible for allergic reactions in up to 15% of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in